improving Oncology study with Integrated KRAS Assay products and services and RAS Assays
from the swiftly evolving field of oncology investigate, correct and efficient mutation screening is very important for producing targeted therapies. The KRAS solutions Platform performs a pivotal position On this landscape by providing thorough methods for KRAS mutation profiling and analysis. KRAS mutations, present in approximately ninety five%